PMID: 9163620May 1, 1997Paper

Collection of peripheral blood stem cells from normal donors 60 years of age or older

British Journal of Haematology
P AnderliniM Körbling

Abstract

We report 14 normal peripheral blood stem cell (PBSC) donors > or = 60 years of age who had cytokine mobilization followed by PBSC apheresis for allogeneic transplantation. Mobilization was achieved with filgrastim (6 microg/kg twice daily). Their median age was 63.5 years (range 60-77), and 43% had a positive medical history, mainly hypertension and/or cardiac problems. Their median pre-apheresis leucocyte count (x 10(9)/l) was 38.6 (range 29.6-63.4). The median apheresis yield (x 10(6) CD34+ cells/litre blood processed, first apheresis) was 27.9 (range 1.6-54.8). The target cell dose (> or = 4 x 10(6) CD34+ cells/kg recipient) was reached with one procedure in eight (57%) donors. Filgrastim-related adverse events were acceptable and apheresis was well tolerated. When compared to younger donors (< 60 years of age), a trend to a lower CD34+ apheresis yield and a requirement for more than one apheresis to achieve the collection target (> or = 4 x 10(6) CD34+ cells/kg) was evident. Although older (> or = 60 years) donors seem to mobilize less effectively, these data suggest that PBSC collection from them is feasible and has an acceptable short-term safety profile.

Citations

Mar 17, 2004·Current Opinion in Immunology·Frances T HakimRonald E Gress
Jun 18, 2005·Seminars in Immunology·Valerie P Zediak, Avinash Bhandoola
Feb 13, 2001·Mechanisms of Ageing and Development·R B Effros
Mar 16, 2002·Transfusion·Javier de la RubiaUNKNOWN Spanish Group of Allogeneic Peripheral Blood Stem Cell Transplantation
Sep 21, 2010·Cardiovascular Research·Winston ShimPhilip Wong
Apr 17, 2001·Current Opinion in Hematology·F Gutierrez-Delgado, W Bensinger
May 7, 2009·Stem Cells·Nuria GagoAnder Izeta
Feb 12, 2011·Journal of Clinical Apheresis·Daniel LysákPavel Jindra
Jun 16, 2015·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Fatih Kurnaz, Leylagül Kaynar
Apr 2, 2002·Best Practice & Research. Clinical Haematology·N H Russell, J L Byrne
Oct 14, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Elie RichaAndrew Artz
Aug 29, 2014·Journal of Transplantation·Winston Costa PereiraAbdulaziz Al Abdulaaly
Sep 26, 2016·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Zhi-Ping GuoYing-Jun Chang
Oct 8, 2005·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Daniel LysákPavel Jindra
Dec 4, 2002·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·N ShimizuY Saito
Aug 7, 2001·Reviews in Clinical and Experimental Hematology·W I Bensinger, R Storb
Jun 4, 1999·Journal of Clinical Apheresis·P PerseghinG Sciorelli
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M EngelhardtJ Finke
Nov 24, 2020·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Semih BaşcıFevzi Altuntaş

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.